Results 81 to 90 of about 37,864 (312)

Evaluation of Contemporary Echocardiographic and Histomorphology Parameters in Predicting Mortality in Patients With Endomyocardial Biopsy-Proven Cardiac AL Amyloidosis [PDF]

, 2022
INTRODUCTION: This study examined the role of echocardiographic and cardiac histomorphology parameters in predicting mortality in patients with cardiac AL amyloidosis.
Ali, Abdelrahman, Banchs, Jose, Black, Christopher K, Buja, L Maximilian, Deswal, Anita, Durand, Jean-Bernard, Iliescu, Cezar, Koutroumpakis, Efstratios, Lee, Hans C, Niku, Adam, Palaskas, Nicolas, Sadaf, Humaira, Song, Juhee, Yusuf, Syed Wamique   +13 more
core   +2 more sources

CNN-based Cardiac Motion Extraction to Generate Deformable Geometric Left Ventricle Myocardial Models from Cine MRI [PDF]

arXiv, 2021
Patient-specific left ventricle (LV) myocardial models have the potential to be used in a variety of clinical scenarios for improved diagnosis and treatment plans. Cine cardiac magnetic resonance (MR) imaging provides high resolution images to reconstruct patient-specific geometric models of the LV myocardium. With the advent of deep learning, accurate
arxiv  

State of precision medicine for heart failure with preserved ejection fraction in a new therapeutic age

ESC Heart Failure, EarlyView.
Abstract Heart failure with preserved ejection fraction (HFpEF) is defined by heart failure (HF) with a left ventricular ejection fraction (LVEF) of at least 50%. HFpEF has a complex and heterogeneous pathophysiology with multiple co‐morbidities contributing to its presentation. Establishing the diagnosis of HFpEF can be challenging.
Roy Rasalam, Andrew Sindone, Gary Deed, Ralph G. Audehm, John J. Atherton   +4 more
wiley   +1 more source

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging [PDF]

, 2019
Cardiac amyloidosis is a form of restrictive infiltrative cardiomyopathy that confers significant mortality. Due to the relative rarity of cardiac amyloidosis, clinical and diagnostic expertise in the recognition and evaluation of individuals with ...
Ando, Y, Bokhari, S, Bourque, JM, Dispenzieri, A, Dorbala, S, Falk, RH, Ferrari, VA, Fontana, M, Gheysens, O, Gillmore, JD, Glaudemans, AWJM, Hanna, MA, Hazenberg, BPC, Kristen, AV, Kwong, RY, Maurer, MS, Merlini, G, Miller, EJ, Moon, JC, Murthy, VL, Quarta, CC, Rapezzi, C, Ruberg, FL, Shah, SJ, Slart, RHJA, Verberne, HJ   +25 more
core   +3 more sources

Cardiac Amyloidosis: Clinical Features, Pathogenesis, Diagnosis, and Treatment [PDF]

Türk Patoloji Dergisi
Cardiac amyloidosis is a type of amyloidosis that deserves special attention as organ involvement significantly worsens the prognosis. Cardiac amyloidosis can be grouped under three main headings: immunoglobulin light chain (AL) amyloidosis that is ...
Asuman ARGON, Deniz NART, Funda YILMAZ BARBET   +2 more
doaj   +1 more source

Non‐cardiac biopsy sites with high frequency of transthyretin amyloidosis

ESC Heart Failure, 2021
Aims Cardiac scintigraphy, a non‐invasive technique for diagnosing ATTR cardiac amyloidosis, lacks specificity in patients with concomitant monoclonal gammopathy (up to 40% of cases).
Surendra Dasari, Angela Dispenzieri, Shareef Mansour, Prasuna Muppa, Paul J. Kurtin, Jason D. Theis, Julie A. Vrana, Martha Grogan, Taxiarchis Kourelis, Morie A. Gertz, Ellen D. McPhail   +10 more
doaj   +1 more source

Treatment patterns, outcomes and healthcare resource utilization of obstructive hypertrophic cardiomyopathy in England

ESC Heart Failure, EarlyView.
Abstract Aims Describe patient characteristics, treatment patterns, clinical outcomes, healthcare resource utilization (HCRU) and medical costs associated with patients who were diagnosed with obstructive hypertrophic cardiomyopathy (HCM) in clinical practice in England.
Faizel Osman, Carla L. Zema, Michael Hurst, Belinda Sandler, Florence Brellier, Ovie Utuama, Oksana Kirichek, John Houghton, Teresa Lemmer, Maite Tome Esteban   +9 more
wiley   +1 more source

DMCVR: Morphology-Guided Diffusion Model for 3D Cardiac Volume Reconstruction [PDF]

arXiv, 2023
Accurate 3D cardiac reconstruction from cine magnetic resonance imaging (cMRI) is crucial for improved cardiovascular disease diagnosis and understanding of the heart's motion. However, current cardiac MRI-based reconstruction technology used in clinical settings is 2D with limited through-plane resolution, resulting in low-quality reconstructed ...
arxiv  

Prevalence and prognostic value of different iron deficiency definitions in light chain cardiac amyloidosis patients

ESC Heart Failure, EarlyView.
Non‐scaled Venn diagram of iron deficiency (ID) according to various definitions and associated outcomes. The prevalence of iron deficiency was high, irrespective of the definition applied. ID defined by TSAT <20% or serum iron <13 μmol/L, rather than the guideline definition, was associated with worse outcomes.
Xinqing Li, Anran Xin, Yan Huang, Qiong Zhou, Jinxi Wang, Ping Zhou, Stefan D. Anker, Yuhui Zhang   +7 more
wiley   +1 more source

Tissue Characterization in Cardiac Amyloidosis

Biomedicines, 2022
Cardiac amyloidosis (CA) has long been considered a rare disease, but recent advancements in diagnostic tools have led to a reconsideration of the epidemiology of CA. Amyloid light-chain (AL) and transthyretin (ATTR) amyloidoses are the most common forms
Veronica Musetti, Francesco Greco, Vincenzo Castiglione, Alberto Aimo, Cataldo Palmieri, Dario Genovesi, Assuero Giorgetti, Michele Emdin, Giuseppe Vergaro, Liam A. McDonnell, Angela Pucci   +10 more
doaj   +1 more source